Position in TXG
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,289,108
New position
Shares Held
216,200
first reported quarter
Ownership
0.166%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 86%
Shared 0%
None 14%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $27,654,363 across 8 Medical Devices names. TXG ranks #2 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
907,739 | $8,569,056 | |
| 2 | TXG |
10x Genomics, Inc.
This page
|
216,200 | $8,289,108 | |
| 3 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 4 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 5 | NVCR |
NovoCure Ltd
|
141,900 | $2,149,785 | |
| 6 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 7 | APYX |
Apyx Medical Corp
|
182,600 | $819,874 | |
| 8 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in TXG
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,289,108 | 216,200 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||